Cloned transmembrane receptor for 24-hydroxylated vitamin d compounds and uses thereof
AssigneeShriners Hospital For Children
InventorRene St-Arnaud
Life of this patent
Estimating the term…
Abstract
The instant invention relates to the use of 24-hydroxylated vitamin D compounds as therapeutics in mammalian bone fracture repair. In addition, the instant invention relates to novel 24-hydroxylated vitamin D compound receptors which can be employed in the development of compounds capable of facilitating fracture repair in animals. The instant invention also relates to nucleic acids encoding such receptors as well as vectors, host cells, transgenic animals comprising such nucleic acids and screening assays employing such receptors.
Claims6
A method of identifying a compound suitable for enhancing bone fracture repair comprising:
- (a) administering a candidate compound capable of binding to a 24-hydroxylated vitamin D compound receptor to an animal;
- and
- (b) determining whether the animal exhibits a change bone fracture repair, as compared with an animal to which the candidate compound has not been administered;
- thereby identifying a compound for enhancing bone fracture repair.
Dependencies are inferred from the claim text.